Evidence suggests that Semaglutide therapy is associated with improvements in cardiovascular risk markers, including blood pressure and lipid profiles
Under physiological conditions, Nrf2 remains sequestered in the cytoplasm by its inhibitor, the Kelch-like ETC-associated protein 1 (Keap1), but oxidative or electrophilic stress triggers Nrf2 dissociation, nuclear translocation, and binding to antioxidant response elements (AREs), upregulating genes such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione S-transferases (GSTs) (Cuadrado et al., 2019)
To sustain these reactions and ensure high-quality protein output, cells tightly control the ERs metabolic and chemical environment 6
Nausea, vomiting, diarrhea, and constipation are common, especially in the early weeks of treatment